AI
ZOM

Atom Investors’s Zomedica Corp. ZOM Stock Holding History

Atom Investors’s Portfolio ZOM Stock Details ZOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,201,048
Closed -$175K – 717
2024
Q1 		$175K Buy
+1,201,048
New +$168K 0.02% 494
2021
Q4 		– Sell
-171,126
Closed -$90K – 453
2021
Q3 		$90K Buy
+171,126
New +$101K 0.01% 294

Other funds holding ZOM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
BBHC
Brown Brothers Harriman & Co New York $22.8B AUM 25.09% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
BCI
Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return

Atom Investors's ZOM Position: Q2 2024 in Review

Atom Investors sold out of Zomedica Corp. (ZOM) in Q2 2024, closing a stake of 1,201,048 shares — an estimated $175K sold.

Atom Investors first reported a position in ZOM in Q3 2021 and held it in 2 quarters. The position peaked at $175K in Q1 2024. 97 funds tracked by Wall St. Rank hold ZOM as of Q2 2024.

  • Atom Investors reported no remaining Zomedica Corp. position as of Q2 2024 after selling out during the quarter.
  • Atom Investors sold 1,201,048 Zomedica Corp. shares in Q2 2024, an estimated $175K.
  • Atom Investors first reported a position in Zomedica Corp. in Q3 2021 and held it in 2 quarters.
  • Atom Investors's Zomedica Corp. position peaked at $175K in Q1 2024.
  • 97 funds tracked by Wall St. Rank held Zomedica Corp. as of Q2 2024.

Based on Atom Investors's 13F filing for Q2 2024, filed 14 Aug 2024.